Company
heartflow
Heartflow’s vision is to transform CAD from the leading cause of death into a disease that can be managed for life.
Also known as Heartflow, Inc.
- Status
- IPOas of 2026-09-19Source (opens in a new tab)
- Business model
- B2B
- Founded
- 2010
- Customers
- clinicians and healthcare teams
- Legal name
- Heartflow, Inc.
- heartflow.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Heartflow advances coronary care by empowering clinicians with precision tools and insights to optimize care delivery and achieve the best possible outcomes.
Funding snapshot
- Total raised
- $392MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $65M2019-06-11
Funding rounds
- Round, 2019
- $65M2019-06-11, SEC form D sold, 9 investors
- Round, 2017
- $90M2017-11-20, SEC form D sold, 2 investors
- Round, 2015
- $99.9M2015-01-30, SEC form D sold, 25 investors
- Round, 2011
- $105M2011-12-21, SEC form D sold, 29 investors
- Round, 2010
- $20.4M2010-08-23, SEC form D sold, 10 investors
- Round, 2010
- $10M2010-06-04, SEC form D sold, 5 investors
- Round, 2010
- $1.6M2010-04-06, SEC form D sold, 3 investors
- Round, 2009
- $195K2009-07-02, SEC form D sold, 3 investors
About the company
- Status notes
- Became a Public Company (Nasdaq: HTFL)
Products
- Web
- FFR CT Analysis
- Web
- Heartflow One
- Web
- Plaque Analysis
- Web
- Roadmap Analysis
Loading relationship preview